title: The evolution of personalized cancer genetic counseling in the era of personalized medicine.
abstract: Practice changes in cancer genetic counseling have occurred to meet the demand for cancer genetic services. As cancer genetics continues to impact not only prevention strategies but also treatment decisions, current cancer genetic counseling models will need to be tailored to accommodate emerging clinical indications. These clinical indications include: surgical prophylactic bilateral mastectomy candidates, PARP-inhibitor candidates, patients with abnormal tumor screening results for Lynch syndrome, and post-test counseling patients (after genetic testing is ordered by another healthcare provider). A more personalized, multidisciplinary approach to selecting the best framework, for a given clinical indication, may become increasingly necessary in this era of personalized medicine.
authors.forename: Hetal S
authors.initials: HS
authors.lastname: Vig
authors.forename: Catharine
authors.initials: C
authors.lastname: Wang
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics* / Q000517:prevention & control / Q000601:surgery; D003123:Colorectal Neoplasms, Hereditary Nonpolyposis / Q000175:diagnosis / Q000235:genetics*; D005260:Female; D005817:Genetic Counseling / Q000639:trends*; D006579:Heterozygote; D006801:Humans; D053842:Microsatellite Instability; D057285:Precision Medicine